Compare · SWAV vs SYK
SWAV vs SYK
Side-by-side comparison of Shockwave Medical Inc. (SWAV) and Stryker Corporation (SYK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SWAV and SYK operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- SYK is the larger of the two at $108.02B, about 22.9x SWAV ($4.73B).
- SYK has hit the wire 8 times in the past 4 weeks while SWAV has been quiet.
- SYK has more recent analyst coverage (25 ratings vs 21 for SWAV).
- Company
- Shockwave Medical Inc.
- Stryker Corporation
- Price
- $334.80-0.01%
- $293.33+4.14%
- Market cap
- $4.73B
- $108.02B
- 1M return
- -
- +3.00%
- 1Y return
- -
- -20.53%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2019
- News (4w)
- 0
- 8
- Recent ratings
- 21
- 25
Shockwave Medical Inc.
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. ShockWave Medical, Inc. was incorporated in 2009 and is headquartered in Santa Clara, California.
Stryker Corporation
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Latest SWAV
- Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems
- Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors
- Bruker Appoints Laura Francis to its Board of Directors
- Deborah Kilpatrick Joins Sonder Capital as its Newest Venture Partner
- SEC Form 15-12G filed by Shockwave Medical Inc.
- Francis Laura returned 4,784 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Moll Frederic H returned 287,521 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Papiernik Antoine returned 34,913 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Sainz Maria returned 5,328 shares to the company, closing all direct ownership in the company (SEC Form 4)
- SEC Form S-8 POS filed by Shockwave Medical Inc.
Latest SYK
- Stryker launches Sonopet® 3, delivering greater power and precision in ultrasonic tissue removal
- Stryker and CMR Surgical announce strategic alliance to advance robotic-assisted surgery
- Barclays initiated coverage on Stryker with a new price target
- SEC Form 8-K filed by Stryker Corporation
- Stryker announces leadership succession
- Stryker to announce third quarter 2026 financial results
- VP, Chief Financial Officer Wells Preston Wendell disposed of 109 shares, decreasing direct ownership by 3% to 3,661 units (SEC Form 4)
- VP, Chief Financial Officer Wells Preston Wendell disposed of 2,739 shares, decreasing direct ownership by 42% to 3,770 units (SEC Form 4)
- Stryker showcases Foot & Ankle innovation at AOFAS 2026 with Prophecy® Surgical Planning for Incompass™ and Hoffmann® LRF smartHEX™
- New insider Baculik Emily Kay claimed ownership of 1,554 shares (SEC Form 3)